Company: BIAF
Filing Date: 2025-05-23
Form Type: PRER14A
Source: 0001641172-25-012315
Chunk: 24

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-23
Form: PRER14A
Chunk 24
---
ation to effect a reverse stock split of the issued and outstanding
shares of Common Stock, a copy of which is set forth in the certificate of amendment attached to this Proxy Statement as , declared such amendment advisable, and is recommending that our stockholders approve such proposed amendment. Such amendment will
be effected after stockholder approval thereof only in the event the Board still deems it advisable. Holders of our Common Stock are
being asked to approve the proposal that Section 4 of our Certificate of Incorporation be amended to effect a reverse stock split of
the Common Stock at a ratio in the range of one (1) share of Common Stock for every two (2) shares of Common Stock to one (1) share of
Common Stock for every one hundred (100) shares of Common Stock. If the Reverse Stock Split is approved by our stockholders and if a
certificate of amendment is filed with the Secretary of State of the State of Delaware, the certificate of amendment to our Certificate
of Incorporation will affect the Reverse Stock Split by reducing the outstanding number of shares of Common Stock. If the Board
of Directors does not implement an approved Reverse Stock Split prior to the one-year anniversary of this meeting, this vote will be
of no further force and effect, and the Board will again seek stockholder approval before implementing any reverse stock split
after that time. The Board of Directors may abandon the proposed amendment to effect the Reverse Stock Split at any time prior to its
effectiveness, whether before or after stockholder approval thereof.

As of the Record Date, the Company had
[ ] shares of Common Stock outstanding. For purposes of illustration, if the Reverse Stock Split is effected at a
ratio of 1-for-10, the number of issued and outstanding shares of Common Stock after the Reverse Stock Split would be approximately [
] shares. The Board of Directors’ decision as to whether and when to effect the Reverse Stock Split will be based
on a number of factors, including market conditions, existing and expected trading prices for the Common Stock, and the continued listing
requirements of the Nasdaq Capital Market. See below for a discussion of the factors that the Board considered in determining the Range,
some of which included, but was not limited to, the following: the historical trading price and trading volume of the Common Stock; the
expected impact of the Reverse Stock Split on the trading market for the Common Stock in the short-term and long-term, and general market,
economic conditions, and other related conditions prevailing in our industry.

The